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E-mail address: schuelein@fmp-berlin.de (R. SchülIn this study we demonstrate that the photoconvertible monomeric Kikume green–red (mKikGR)
protein is suitable to study trafﬁcking of G protein-coupled receptors. Taking mKikGR-tagged
mutants of the vasopressin V2 receptor (V2R) as models, we analyzed whether the V2R-speciﬁc phar-
macological chaperone SR121463B inﬂuences receptor folding on a co- or post-translational level.
Misfolded mKikGR-tagged V2Rs were completely photoconverted in the early secretory pathway
yielding a red receptor population (already synthesized receptors) and an arising green receptor pop-
ulation (newly synthesized receptors). Trafﬁcking of both receptor populations could be rescued by
treatment with SR121463B demonstrating that the substance can act co- and post-translationally.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
To date, the green ﬂuorescent protein (GFP) and its derivatives
are the most commonly used fusion proteins to visualize protein
localization and to track protein dynamics in living cells [1–3].
Nevertheless, the GFP methodology has limitations, in particular
in the differentiation of newly synthesized vs. already present pro-
teins in the early secretory pathway. These disadvantages may be
overcome by the use of photoconvertible ﬂuorescent proteins
(pc-FPs) such as the Kaede protein [4] or the recently described
monomeric mKikGR protein [5–6]. Pc-FPs usually change their
ﬂuorescence following UV irradiation from green to red due rear-
rangements in their chromophores and backbone cleavage [7–8].
In the case of membrane proteins, however, only a very limited
amount of studies demonstrate that pc-FPs do not inﬂuence struc-
ture of the fusion partner and can indeed be used as ﬂuorescence
tags. For the Kaede protein, it was shown that it can be used to ana-
lyze recycling and biosynthesis of GPCRs [9–10] and trafﬁcking of
the Kv1.1 voltage-gated potassium channel [11]. In the case of
mKikGR, such studies are missing. To date, the KikGR protein has
only been used to study trafﬁcking of soluble proteins into assem-
bling nuclei [12] or to label cells and embryonic tissues [13–15].chemical Societies. Published by E
ein).Here, we took the G protein-coupled V2R as a model and show that
mKikGR fusions are ideally suited to study GPCR trafﬁcking.
The V2R regulates thewater reabsorption in renal collecting duct
epithelial cells. Binding of the antidiuretic hormone 8-arginine
vasopressin (AVP) to the basolaterally expressed receptor leads to
a Gs-mediated stimulation of the adenylyl cyclase system and to
an increase in cAMP formation. Finally, vesicles containing the
aquaporin 2 water channel (AQP2) fuse with the apical plasma
membrane and increase water ﬂow through the epithelium
[16–17]. Mutations in the genes of the V2R and other GPCRs and
integral membrane proteins frequently lead to misfolded receptors
which are recognized by the quality control system (QCS) of the
early secretory pathway, retained intracellularly and ﬁnally sub-
jected to proteolysis via the ER-associated degradation pathway
(ERAD) [18–20]. Mutationally misfolded V2Rs cause an inherited
disease, namely X-linked nephrogenic diabetes insipidus (NDI),
which is characterized by the inability of the kidney to concentrate
urine [21].
It has been shown for misfolded V2Rs and many other receptors
that smallmolecules, called pharmacological chaperones,may facil-
itate correct folding of the proteins allowing them to pass the QCS of
the early secretory pathway and to reach the plasma membrane
[22–23]. However, it is not completely clear whether pharmacolog-
ical chaperones act co-translationally, i.e. during receptor synthesis,
or post-translationally on the level of fully synthesized receptors. In
the case of the V2R, treatment with the antagonist SR121463Blsevier B.V. All rights reserved.
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it was proposed that SR121463B acts post-translationally [23].
However, an additional co-translational rescue was not excluded.
In addition to provide a proof of principle for the mKikGR technol-
ogy in membrane protein trafﬁcking, we also show here by using
V2R-mKikGR fusions and a novel microscopical cell-based assay
that such a co-translational mechanism of action takes place, too.
2. Materials and methods
2.1. Materials
Trypsin, cycloheximide and Lipofectamine 2000 were pur-
chased from Invitrogen (Leek, The Netherlands). Trypan blue was
purchased from Seromed (Berlin, Germany). Fetal calf serum was
obtained from Biochrom (Berlin, Germany). G418 was obtained
from Calbiochem-Novabiochem (Bad Soden, Germany). The V2R-
selective antagonist SR121463B was kindly provided by Dr. C. Ser-
radeil-LeGal (Sanoﬁ Synthelabo, Montpellier, France). The cDNA
encoding the human V2R has been described previously [27]. The
vectors CoralHue phmKikGR1-MNLinker and CoralHue pKaede-
MN1 were purchased from MBL International (Woburn, MA,
USA). The pEGFP-N1 vector was obtained from BD Biosciences
Clontech (Heidelberg, Germany). The vector pET-30 Ek/LIC and
the Escherichia coli strain Rosetta (DE3) were purchased from
EMD Biosciences (Darmstadt, Germany). The peptide ligand of
the V2R, 8-arginine-vasopressin (AVP) was a gift of M. Beyermann
(Berlin, Germany) [28]. [3H] AVP (68.5 Ci/mmol) and [3H]cAMP
were purchased from PerkinElmer Life Science (Rodgau, Germany).A
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Fig. 1. (A) Schematic representation of the constructs used in this study. The transmemb
domains (only shown for the ﬁrst construct). Kaede, Flag, His and mKikGR tags are indicat
The one-letter code for amino acids is used. Putative transmembrane domains are in
glycosylation at N22, palmitoylation at C341 and C342. The putative disulﬁde-bridge is deThe monoclonal mouse anti-coral Kikume green–red/KikGR anti-
body was purchased from MBL International (Woburn, MA, USA),
the DyLight 680-conjugated anti-mouse IgG was from Biomol
(Hamburg, Germany). Oligonucleotides were synthesized by Biotez
(Berlin, Germany). The Rotiload sample buffer was from Carl Roth
GmbH (Karlsruhe, Germany). All other reagents were purchased
from Sigma–Aldrich (Taufkirchen, Germany).
2.2. DNA manipulations
Site-directed mutagenesis was carried out with the QuikChange
site-directed mutagenesis kit from Stratagene (La Jolla, CA, USA).
The nucleotide sequences of the plasmid constructs were veriﬁed
using the ABI PRISM BigDye Terminator kit from Life Technologies
(Carlsbad, CA, USA).
2.3. Plasmid constructs
The constructs used in this study are schematically shown in
Fig. 1A (details of the cloning procedures on request). Constructs
V2R.Kaede and Flag.V2R encode a C-terminal Kaede fusion to the
V2R and an N-terminally Flag-tagged V2R respectively. Both con-
structs have been described [9,19]. For the construction of a V2R-
mKikGR fusion, the V2R cDNA was cloned into vector plasmid Cor-
alHue phmKikGR1-MNLinker leading to construct V2R.mKikGR.
The resulting receptor is C-terminally tagged with mKikGR, there-
by deleting the stop codon. Using site-directed mutagenesis, the
NDI-causing mutations S167T and R337X were introduced into













rane domains are indicated by boxes. The Roman numerals indicate transmembrane
ed. (B) Topological model of the V2R and location of the S167T and R337X mutations.
dicated by grey boxes. The following post-translational modiﬁcations are shown:
picted between the conserved extracellular cysteine residues C112 and C192.
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minally His-tagged mKikGR protein. It was constructed by cloning
the mKikGR cDNA into the E. coli expression vector pET-30 Ek/LIC.
2.4. Cell culture and transfection
Stably transfected HEK 293 cells were cultured at 37 C and 5%
CO2 in Dulbecco’s modiﬁed Eagle’s medium containing 10% (v/v)
fetal calf serum. Stable transfection of the cells was carried out
with Lipofectamine 2000 according to the supplier’s recommenda-
tions. G418 (400 lg/ml) was used for selection and maintenance of
the cells clones.
2.5. Localization of green mKikGR-tagged constructs by confocal laser
scanning microscopy (LSM)
To localize green mKikGR signals, stably transfected HEK 293
cells expressing the constructs were grown in 35 mm diameter
dishes on glass coverslips coated with 100 mg/ml poly-L-lysine.
After 48 h of incubation, samples were supplemented with
SR121463B (1 lM) or DMSO vehicle (0.1%) and incubated for an-
other 16 h. Coverslips were washed once with phosphate-buffered
saline (PBS), and transferred immediately into a self-made cham-
ber (details on request). Cells were covered with 1 ml of PBS, and
trypan blue was added to a ﬁnal concentration of 0.05% (w/v).
The green mKikGR ﬂuorescence signals were visualized on a Zeiss
LSM510-META inverted confocal LSM (multitrack mode; objective
lens = 100/1.3 oil; optical section <2.0 lm; kexc = 488 nm, Argon
laser, BP ﬁlter = 505–530 nm). Trypan blue ﬂuorescence was re-
corded on a second channel (kexc = 543 nm, He Ne laser, LP ﬁl-
ter = 560 nm), and the overlay with the green mKikGR signals
was computed. Images were imported into PHOTOSHOP CS3 soft-
ware (Adobe Systems, San Jose, CA, USA), and the contrast was ad-
justed to approximate the original image. For the quantitative
analysis of green mKikGR signals at the cell surface or in the cell’s
interior the plasma membrane identiﬁed by the Trypan blue image
was selected as a region of interest (ROI). The ROI was transferred
to the green mKikGR image and a second ROI assigning the cell’s
interior was selected. Thereafter, the ﬂuorescence intensities of
the green mKikGR signals in the plasma membrane (IMem) and
the cell’s interior (ICyt) were measured using the Zeiss LSM510-
META software and the IMem/ICyt ratio was calculated for each sin-
gle cell after background subtraction.
2.6. Analysis of co- and/or post-translational rescue of the constructs
by confocal LSM
Stably transfected HEK 293 cells expressing the constructs were
grown in 35 mm diameter dishes on glass coverslips coated with
100 mg/ml poly-L-lysine. After 48 h of incubation, green mKikGR
signals were completely photoconverted using a 50W mercury
UV lamp for 45 s. Cells were treated for another 16 h with
SR121463B (1 lM) or DMSO vehicle (0.1%). The arising green
mKikGR signals were localized by confocal LSM as described above
but without Trypan blue treatment. The cellular fate of the red
mKikGR signals was anlayzed on the microscope described above
(singletrack mode; objective lens = 100/1.3 oil; optical section
<2.0 lm; kexc = 543 nm, Argon laser, LP ﬁlter = 560 nm). For the
quantitative analysis of red mKikGR signals at the cell surface no
plasmamembranemarker was used, since the available cell surface
stain compatible with the red mKikGR ﬂuorescence (CellMask Dee-
pRed) internalizes rapidly in live cells. Here, green mKikGR signals
reappearing clearly at the cell boundaries following SR121463B
treatment were used to approximate the dimensions of the plasma
membrane and to deﬁne the plasmamembrane ROI. Thereafter, the
ﬂuorescence intensities of the red mKikGR signals in the plasmamembrane (IMem) and the cell’s interior (ICyt) were measured equiv-
alent to what was described for the green mKikGR signals above
and the IMem/ICyt ratio was calculated for each single cell.
2.7. [3H] AVP binding assay and cAMP accumulation assay
Speciﬁc [3H]AVP binding to stably transfected intact HEK 293
cells and the cAMP accumulation assay (cAMP RIA) were carried
out as described [28,29]. Data were analyzed using the programs
RadLig 6.0 (Cambridge, UK) and GraphPad Prism 3.02 (GraphPad
Software, San Diego, Ca, USA).
2.8. Expression, puriﬁcation and limited proteolysis of green and red
mKikGR
The construct His-mKikGR was transformed in E. coli Rosetta
(DE3). Recombinant protein expression was induced by 1 mM iso-
propyl-b-D-1-thiogalactopyranoside (IPTG) for 2 h. The His-mKikGR
protein was puriﬁed using metal chelate afﬁnity chromatography.
To induce photoconversion of green mKikGR to red mKikGR, the
puriﬁed protein was irradiated by a mercury lamp for 30 min. Iso-
lated g-mKikGR and r-mKikGR (3 mg each) were digested using
trypsin (1, 10, 20, 200 mg/ml) for 60 min at 4 C. Digested samples
were analyzed by SDS–PAGE/immunoblotting as described previ-
ously [30] and detected using a monoclonal anti-mKikGR antibody
(1:1000 dilution) and DyLight 680-conjugated anti-mouse IgG
(1:10.000 dilution). Immunoreactive protein bands were visualized
using the Odyssey infrared imaging system and its application soft-
ware 2.1 (Li-COR Biosciences, Lincoln, Ne, USA).
2.9. Fluorescence correlation spectroscopy (FCS)
HEK 293 cells were transiently transfected with vector plas-
mids CoralHue phmKikGR1-MCLinker and Coral Hue pKaede-
MN1 encoding untagged soluble mKikGR and Kaede respectively.
FCS measurements were performed essentially as described [9] at
room temperature on an LSM 710–ConfoCor 3 system (Carl Zeiss
MicroImaging GmbH, Germany) using a C-apochromatic-cor-
rected 40/1.2 water objective. For one measurement, ten FCS
traces (2 s each) were recorded and averaged. Excitation of green
mKikGR and Kaede was achieved using the 488 nm line of an ar-
gon laser. Excitation of the red ﬂuorescence of both constructs
was realized using a diode-pumped solid state laser at 561 nm.
In the beginning, green mKikGR and green Kaede were irradiated
using a 405 nm diode laser until 50% of the ﬂorescence was con-
verted to red. For both ﬂuorescences, a main beam splitter 488/
561 and a dichroic beam splitter with a neutral ﬁlter 565 were
used. To detect the green ﬂuorescence signals, an emission ﬁlter
of band pass 505–550 nm was used, for the red ﬂuorescence sig-
nals, a 580 nm long pass emission ﬁlter was used. The correlator
binning was 0.20 ls. The measured data for the cytosolic proteins
were ﬁtted by the LSM710 software ZEN 2010 (Carl Zeiss MicroI-
maging GmbH, Germany) assuming a three dimensional diffusion
of one component. Average autocorrelation and cross-correlation
curves were derived from the ﬂuctuations using the LSM 7 soft-
ware ZEN 2010. For average calculations, only convergent curves
were used. The curves were normalized to the correlation ampli-
tude for display purposes. The principles of FCS and its use with
confocal laser scanning systems have been described previously
[31–32].
2.10. Statistics
Analyses were performed using the student’s t-test (GraphPad
t-test calculator, GraphPad Software, Inc., La Jolla, CA, USA); P val-
ues <0.0001 were considered to be extremely signiﬁcant.
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3.1. Cytosolic mKikGR is a monomeric protein
The mKikGR protein was engineered out of the originally tetra-
meric KikGR by 21 amino acid residue replacements [5]. The mono-
meric state of mKikGR was veriﬁed mainly by measuring its
molecular mass (31 kDa) by analytical equilibrium ultracentrifuga-
tion [5]. We aimed to fuse mKikGR with GPCRs and even the pres-
ence of minor amounts of tetrameric mKikGR would represent a
signiﬁcant drawback for this purpose. To preclude this possibility,
we reassessed the monomeric nature of mKikGR. To this end, we
analyzed the oligomerization state of soluble non-fused mKikGR
by ﬂuorescence correlation spectroscopy (FCS) measurements. By
analyzing the diffusion properties of proteins at a single molecule
level within a confocal volume, the FCS technology is very sensitive
[33]. The ﬂuorescence intensity of one ﬂuorescent protein can be
measured as a function of time and consequently be auto-corre-
lated; the ﬂuorescence intensities of two different ﬂuorophores
can be cross-correlated. A conﬁrmed cross correlation would indi-
cate co-diffusion of the ﬂuorophores in the confocal volume and
consequently their interaction [34]. In the case of pc-FPs, oligomer-
































Fig. 2. Analysis of the oligomerization state of soluble mKikGR. (A) Subcellular localizatio
or g-Kaede, left panel) and the signals of the plasma membrane marker Trypan blue (red
The horizontal (xy) scans show representative cells of three independent experime
measurements of mKikGR and Kaede. Approximately 50% of the green ﬂuorescence sig
mKikGR or r-Kaede) prior to the FCS measurements and the laser was focused in the cyto
green and red, respectively. Cross-correlation (CC) curves are shown in black. Curves are r
correlation data obtained above. Columns represent mean values (n > 20 cells) of cross-co
case of green and red Kaede signals indicates oligomeric/tetrameric molecules [9]. In co
monomers (background value of two independent ﬂuorophores after cotransfection = 5%photoconversion and cross-correlation analysis of the resulting
two populations of ﬂuorophores (green and red).
To assess for the monomeric state of mKikGR, HEK 293 cells
were transiently transfected with non-fused mKikGR. As a control,
we used non-fused Kaede known to form tetramers. Detection of
the ﬂuorescence signals of the pc-FPs in the cells by confocal laser
scanningmicroscopy revealed that both proteins did not co-localize
with the plasma membrane marker trypan blue and are thus
located in the cytosol as expected (Fig. 2A). Next, cells were
UV-irradiated until 50% of the ﬂuorophores were photoconverted
and the FCS measurements were performed using a laser beam
focused in the cytosol. The normalized autocorrelation and cross-
correlation curves were derived using a one component model of
free diffusion in three dimensions as described [9] (Figs. 2B and
2C). In contrast to Kaede, no cross-correlation was observed for
mKikGR demonstrating that the protein is indeed unable to
oligomerize as shown previously [5].
3.2. The stability of mKikGR is not signiﬁcantly inﬂuenced by
photoconversion
Another prerequisite for the use of mKikGR as a fusion tag for


















n of mKikGR and Kaede. The green ﬂuorescence signals of the constructs (g-mKikGR
, central panel) were recorded by confocal LSM and computer overlaid (right panel).
nts. Scale bar: 5 lm. (B) Normalized auto and cross-correlation curves of FCS
nals of both constructs (g-mKikGR or g-Kaede) were photoconverted to the red (r-
sol. Autocorrelation (AC) curves of green and red ﬂuorescence signals are depicted in
epresentative of three independent experiments. (C) Statistical analysis of the cross-
rrelation of both constructs in per cent (±S.D.). The 30% cross-correlation value in the
ntrast, the cross-correlation of mKikGR (6%) is negligible indicating the presence of
; data not shown) (⁄⁄⁄P < 0.0001; student’s t-test).
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Fig. 3. Trypsin sensitivity assay. Afﬁnity-puriﬁed His-mKikGR was photoconverted
by UV irradiation to red mKikGR (r) or left untreated (green mKikGR, g). Both forms
(3 mg each) were digested with increasing amounts of trypsin (0, 1, 20 and 200 mg/
ml) for 1 h at 4 C. Digested samples were analyzed by SDS–PAGE/immunoblotting.
Proteins were visualized using a monoclonal a-KikGR antibody and DyLight 680-
conjugated anti-mouse IgG. The asterisks indicate an immunoreactive protein band
with an apparent molecular mass of approx. 10 kDa which may result from
incomplete SDS resistance of the photoconverted and backbone-cleaved red
mKikGR (see the text for details). The immunoblot is representative of three
independent experiments.
788 I. Ridelis et al. / FEBS Letters 586 (2012) 784–791are of similar stability. This is not a matter of course since UV irra-
diation and photoconversion leads to an irreversible backbone
cleavage between Na and Ca of residue H62 of mKikGR as a result
of a ß-elimination reaction [7–8,35] Such a chromophore rear-
rangement could impair protein stability and consequently limit
the red KikGR analysis time. We thus addressed the question,
whether photoconversion inﬂuences proteolytic stability of




























Fig. 4. (A) Subcellular location of constructs V2R.mKikGR, S167T.mKikGR and R337X.mK
vehicle (DMSO) or with SR121463B. The receptor’s green mKikGR signals were recorde
visualized by trypan blue staining (central panels, red) and the signals were overlaid (low
xy scans and are representative of three independent experiments. Scale bar, 10 lm. (
intracellular green mKikGR ﬂuorescence intensities (IMem/ICyt) was determined. Colums r
test).see Fig. 1A) was expressed in the E. coli strain Rosseta DE3 and iso-
lated. The puriﬁed protein was photoconverted using a mercury
lamp (red mKikGR) or left untreated (green mKikGR). Green and
red mKikGR were incubated with HEK 293 cell lysates at 37 C
for 1 h and analyzed by SDS–PAGE immunoblot analysis. Neither
green nor red mKikGR degradation was observed suggesting that
both forms are resistant to cellular proteases (data not shown).
Puriﬁed green and red mKikGR were also exposed to increasing
concentrations of trypsin and detected by SDS–PAGE/immunoblot-
ting (Fig. 3). The degradation pattern was roughly similar for green
and red mKikGR conﬁrming that the protein is not destabilized to a
major extend by the photoconversion-induced backbone cleavage.
Thus, as described for the related Kaede protein [4] [9], it is con-
ceivable that the two fragments of red KikGR resulting from back-
bone cleavage (calculated molecular weights = 8 and 23 kDa) form
a tight complex. However, the complex seems to be not completely
SDS-resistant during SDS–PAGE: it is likely that the small immuno-
reactive protein band observed following photoconversion even
without trypsin treatment (marked with an asterisk in Fig. 3) rep-
resents the 8 kDa fragment of red mKikGR (the 23 kDa fragment
may have lost the epitope and thus not be detectable).
3.3. C-terminal fusion of mKikGR neither inﬂuences the trafﬁcking nor
the pharmacological properties of wild type and mutant V2Rs
In order to determine of whether mKikGR fusions affect the
properties of GPCRs, we fused the wild-type V2R and the trafﬁck-
ing-defective mutants S167T [23,36–37] and R337X [38–41] at
their C terminus with mKikGR (constructs V2R.mKikGR,













ikGR in HEK 293 cells using confocal LSM. Stably transfected cells were treated with
d (g-mKikGR, upper panels, green). The plasma membrane of the same cells was
er panels; colocalization is indicated by yellow colour). The images show horizontal
B) Quantitative analysis of the above results. The ratio of plasma membrane and
epresent mean IMem/ICyt values of at least 35 cells (±S.D.) (⁄⁄⁄P < 0.0001; student’s t-
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dressed the question of whether the tag inﬂuences the trafﬁcking
properties of the receptors. To this end, colocalization of the recep-
tor’s green mKikGR ﬂuorescence signals with the plasma mem-
brane marker Trypan blue was analyzed using confocal LSM in
live, stably transfected HEK 293 cells (Fig. 4A and B). Whereas con-
struct V2R.mKikGR was located mainly at the plasma membrane,
both mutant receptors could be only detected in reticular intracel-
lular compartments. These results are entirely consistent with
those obtained for the corresponding GFP-tagged constructs
[23,40–42]. We also treated the cells with the pharmacological
chaperone SR121463B (1 lM, 16 h) in order to see whether traf-
ﬁcking of the mKikGR-tagged receptors could be restored. Trafﬁck-
ing of both mutant receptors to the plasma membrane could be
rescued by SR121463B treatment (Fig. 4A and B), again consistent
with what was described for non- or GFP-tagged mutant receptors
[22–23,43–45]. Taken together, these data show that C-terminal
mKikGR fusions do not affect the trafﬁcking properties of wild type
and mutant V2Rs.
Next, we compared the pharmacological properties of C-termi-
nal mKikGR-tagged, C-terminal Kaede-tagged [9] and N-terminal
Flag-tagged [19] wild type V2Rs in stably transfected HEK 293 cells.
To this end [3H]AVP displacement assays were performed (Fig. 5A).
The curves of V2R.mKikGR and V2R.Kaede overlapped roughly, the
Ki values were similar (V2R.mKikGR = 2.2 ± 1.1 nM; V2R.Kae-
de = 2.7 ± 1.0 nM) and consistent with those previously publishedB
A

















































Fig. 5. Pharmacological properties of the constructs V2R.mKikGR, V2R.Kaede and
Flag.V2R in stably transfected HEK 293 cells. (A) [3H]AVP displacement assay. Intact
cells were supplemented with increasing concentrations of the unlabeled agonist,
and speciﬁc binding of [3H]AVP was determined. Data points represent mean values
(±S.D.) of three independent experiments, each performed in triplicates. Maximal
(non-relative) binding values (dpm  103/well ± S.E.M.) in the experiments indi-
cating expression of the constructs were: Flag V2R; 14.9 ± 1.5; V2R.mKikGR,
5.7 ± 1.3; V2R.Kaede, 2.8 ± 0.4. (B) Concentration response curves. AVP-mediated
cAMP formation was measured by a cAMP RIA. Data points represent mean values
(±S.D.) of three independent experiments, each performed in triplicates. Maximal
(non-relative) values for cAMP formation (pmol/well, 95% CI) in the experiments
were: Flag V2R; 1646 (1531–1762); V2R.mKikGR, 628 (584–672); V2R.Kaede, 958
(909–1008).[9,46] In the case of construct Flag.V2R, a slightly right-shifted dis-
placement curve and an increased Ki value (11.3 ± 1.4 nM) were
observed indicating that the Flag tag may impair ligand binding
to a minor extend. To compare receptor activation, we analyzed
AVP-mediated cAMP formation in stably transfected HEK 293 cells
(cAMP RIA, Fig. 5B). The concentration response curves of
V2R.mKikGR and V2R.Kaede and the corresponding EC50 values
were very similar [0.4 nM (0.2–0.8) vs. 0.2 nM (0.1–0.3) respec-
tively] and in good agreement with published results for the V2R
[9]. In the case of construct Flag.V2R, the concentration response
curve was slightly right-shifted, too [EC50 = 2.1 nM (1.6–2.7)]. Ta-
ken together, these data demonstrate that mKikGR fusions do not
signiﬁcantly inﬂuence the pharmacological properties of the V2R.
3.4. The pharmacological chaperone SR121463B acts co- and post-
translationally
After providing a proof of concept for the feasibility of the
mKikGR technology in the case of the V2R, we studied whether
the pharmacological chaperone SR121463B inﬂuences receptor
folding on a co- and/or post-translational level. The green mKikGR
ﬂuorescence signals of mutants S167T.mKikGR and R337X.mKikGR
were completely photoconverted to red in stably transfected HEK
293 cells using a standard UV lamp. Analysis of the cells by confo-
cal LSM reveals a resulting red ﬂuorescent population, representing
already synthesized receptors, and an arising green population,
representing newly synthesized receptors (Fig. 6A and B). We then
treated the cells with SR121463B (1 lM, 16 h) and analyzed which
of the two receptor populations could be rescued. In the case of
mutant S167T.mKikGR, the green but not the red population was
rescued indicating that SR121463B is unable to act at the post-
translational level. Here, the rescue must be mediated only co-
translationally. In the case of mutant R337X.KikGR, however, both
receptor populations were rescued indicating that SR121463B acts
in this case post-translationally. A concomitant co-translational
rescue is likely for mutant R337X.KikGR but it can not be con-
cluded from this experiment whether the green cell surface popu-
lation results from co- or post-translationally-rescued receptors.4. Discussion
We have conﬁrmed by FCS measurements that mKikGR is
monomeric [5] in a cellular environment and that its stability is
not changed following photoconversion. C-terminally fused
mKikGR neither affects the trafﬁcking nor the pharmacological
properties of wild type and mutant V2Rs. Thus, mKikGR fusions
may be a powerful tool to study GPCR and membrane protein traf-
ﬁcking in the future. Most importantly, mKikGR ﬂuorescence can
be switched once the target protein has reached a particular mem-
brane compartment by UV irradiation. The tag thus seems to be
ideally suited to study protein trafﬁcking between different subcel-
lular compartments. Another pc-FP, namely the Kaede protein, was
already used to study real time GPCR recycling [9] and biosynthesis
[10]. Kaede seems not to oligomerize when fused to membrane
proteins but is prone to tetramerize in its soluble form [9]. The
mKikGR protein may replace Kaede in these type of studies since
it is always monomeric, even when fused to soluble proteins.
It was previously proposed that the pharmacological chaperone
SR121463B acts post-translationally [23]. A co-translational mech-
anism of action, however, has not been excluded. Indeed, we show
here following complete photoconversion of KikGR-tagged trafﬁck-
ing-defective V2R mutants that the substance may act by both
mechanisms. However, surprising differences were observed in
the mode of action for the individual mutants: Whereas mutant

























Fig. 6. (A) SR121463B-mediated co- and/or post-translational rescue of constructs S167T.mKikGR and R337X.mKikGR in stably transfected HEK 293 cells. The green mKikGR
ﬂuorescence signals of the mutants were completely photoconverted using a standard UV lamp and cells were treated with SR121463B (+) or with vehicle (). The subcellular
fate of the resulting red (r-mKikGR) and arising green (g-mKikGR) receptor populations were recorded after 16 h of incubation by confocal LSM. The images show horizontal
xy scans and are representative of three independent experiments. The arrow indicates the rescued red ﬂuorescent R337X.mKikGR constructs at the plasma membrane. Scale
bar, 10 lm. (B) Quantitative analysis of the red mKikGR signals following SR121463B treatment. The ratio of plasma membrane and intracellular red mKikGR ﬂuorescence
intensities (IMem/ICyt) was determined. Colums represent mean IMem/ICyt values of at least 30 cells (±S.D.) (⁄⁄⁄P < 0.0001; student’s t-test).
790 I. Ridelis et al. / FEBS Letters 586 (2012) 784–791was rescued post-translationally (and presumably also co-transla-
tionally). These differences may result from a variable folding of
the binding cleft in both mutants in the early secretory pathway.
In the case of the R337X mutation, the helix 8 of the intracellular
C terminus of the receptor is truncated by the mutation. The fold-
ing defect leading to recognition by the QCS might be less severe
and the integrity of the binding pocket may remain intact. The
pharmacological chaperone SR121463B may consequently bind
even when the mutant receptor is fully synthesized and stabilize
correct folding or induce refolding. Consistent with a less severe
defect of the R337X mutant are data showing that this mutant
may reach post ER compartments such as the ER/Golgi intermedi-
ate compartment [40]. On the other hand, the S167T mutant seems
to be retained more exclusively in the ER suggesting a more pro-
found folding defect [42]. Due to such a more serious defect, the
binding pocket may be inaccessible for SR121463B when the
receptor is fully synthesized and the substance may consequently
bind only during early receptor biosynthesis. It may represent a
catalyst for correct building of the binding cleft and consequently
for correct folding of the full length receptor.
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